Patricia Ohana
Directeur Technique/Scientifique/R&D chez The Hebrew University of Jerusalem
Profil
Patricia Ohana is currently working as a Research Scientist in the Biological Chemistry Department at The Hebrew University of Jerusalem.
Previously, she worked as a Vice President in Clinical Development at BioCancell Therapeutics, Inc.
Postes actifs de Patricia Ohana
| Sociétés | Poste | Début |
|---|---|---|
| The Hebrew University of Jerusalem | Directeur Technique/Scientifique/R&D | - |
Anciens postes connus de Patricia Ohana
| Sociétés | Poste | Fin |
|---|---|---|
BioCancell Therapeutics, Inc.
 BioCancell Therapeutics, Inc. BiotechnologyHealth Technology BioCancell Therapeutics, Inc. is a development-stage biopharmaceutical company, which is focused on the discovery, development and commercialization of novel therapies for treating cancer-related diseases. The company's technology offers a safe and long-term treatment of cancer, with no adverse effects. The drug candidates developed by the company are targeted and its target is to selectively destroy the cancer cells without affecting healthy cells. BioCancell was founded on July 26, 2004 by Avraham Hochberg and is headquartered in Jerusalem, Israel. | Directeur Technique/Scientifique/R&D | 14/10/2010 |
Expériences
Fonctions occupées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Entreprise privées | 1 |
|---|---|
BioCancell Therapeutics, Inc.
BioCancell Therapeutics, Inc. BiotechnologyHealth Technology BioCancell Therapeutics, Inc. is a development-stage biopharmaceutical company, which is focused on the discovery, development and commercialization of novel therapies for treating cancer-related diseases. The company's technology offers a safe and long-term treatment of cancer, with no adverse effects. The drug candidates developed by the company are targeted and its target is to selectively destroy the cancer cells without affecting healthy cells. BioCancell was founded on July 26, 2004 by Avraham Hochberg and is headquartered in Jerusalem, Israel. | Health Technology |